Profile data is unavailable for this security.
About the company
Magnasense AB, formerly AegirBio AB is a Sweden-based medicine company focused therapeutic drug monitoring of biologic therapies in the autoimmune, oncology and neurology space. The Company offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. It aims to provide personalized treatment by tracking drugs levels in individuals. Magnasense AB combines core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Sweden, which owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a California-based biotech, which is a developer of the Veritope chemistry platform for detecting levels of biologic drugs in patient samples.
- Revenue in SEK (TTM)36.00k
- Net income in SEK-49.38m
- Incorporated2019
- Employees14.00
- LocationMagnasense ABScheelevagen 27LUND 223 63SwedenSWE
- Phone+46 462865400
- Websitehttps://aegirbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qlife Holding AB | 121.00k | -151.53m | 3.29m | 11.00 | -- | -- | -- | 27.23 | -0.2358 | -0.2358 | 0.0002 | -0.0032 | 0.001 | 2.43 | 0.2999 | 5,041.67 | -128.65 | -- | -255.39 | -- | -15,523.97 | -- | -125,228.90 | -- | 0.2348 | -26.54 | -- | -- | -98.64 | -- | -71.74 | -- | -- | -- |
| Audientes A/S | 1.68m | -19.34m | 8.46m | 11.00k | -- | 2.63 | -- | 5.02 | -0.2215 | -0.2215 | 0.0106 | 0.0098 | 0.0648 | 0.0331 | 4.71 | 97.27 | -74.36 | -47.21 | -207.54 | -64.67 | 87.57 | -- | -1,148.04 | -4,172.60 | 0.1311 | -8.45 | 0.01 | -- | 1,502.53 | -- | 44.98 | -- | -- | -- |
| S2Medical AB (publ) | 10.31m | -17.12m | 10.75m | 17.00 | -- | 4.92 | -- | 1.04 | -0.1381 | -0.1381 | 0.0522 | 0.0089 | 0.4704 | 0.3155 | 11.73 | 606,255.90 | -78.15 | -65.16 | -720.95 | -101.50 | 82.25 | 65.03 | -166.14 | -220.19 | 0.213 | -1.36 | 0.00 | -- | 49.27 | 36.05 | 22.91 | -- | -14.81 | -- |
| Magnasense AB | 36.00k | -49.38m | 15.00m | 14.00 | -- | -- | -- | 416.60 | -2.18 | -2.18 | 0.0015 | -0.3413 | 0.0005 | -- | 0.0065 | 2,571.43 | -67.93 | -- | -82.25 | -- | 355.56 | -- | -137,155.60 | -- | 0.5183 | -43.54 | 1.40 | -- | -94.61 | -- | 83.55 | -- | -- | -- |
| Perpetua Medical AB (publ) | 6.58m | -11.98m | 15.30m | 4.00 | -- | 1.23 | -- | 2.33 | -0.3955 | -0.3955 | 0.115 | 0.1144 | 0.4504 | 3.93 | 3.38 | -- | -81.98 | -83.52 | -107.92 | -102.19 | 57.86 | 63.46 | -182.03 | -250.30 | 5.52 | -- | 0.00 | -- | -1.76 | 57.20 | 4.63 | -- | 8.89 | -- |
| Level Bio AB (publ) | 23.85m | -11.38m | 22.19m | 13.00 | -- | 2.79 | -- | 0.9303 | -0.1794 | -0.1794 | 0.3762 | 0.1256 | 1.14 | 4.08 | 5.71 | 1,834,817.00 | -54.52 | -6.39 | -79.18 | -10.51 | -0.1479 | -- | -47.69 | -4.09 | 0.9424 | -- | 0.00 | -- | -23.10 | 7.83 | -326.08 | -- | -4.64 | -- |
| VibroSense Dynamics AB | 2.08m | -7.61m | 22.86m | -- | -- | 3.06 | -- | 11.00 | -0.5156 | -0.5156 | 0.1325 | 0.292 | 0.1889 | 0.1441 | 9.78 | -- | -69.18 | -46.24 | -85.81 | -53.08 | 94.02 | 85.61 | -366.26 | -551.22 | 3.09 | -- | 0.00 | -- | 22.89 | 29.61 | 6.88 | -- | -5.74 | -- |
| Neodynamics AB (publ) | 327.31k | -87.19m | 26.42m | -- | -- | 0.5524 | -- | 80.70 | -37.52 | -37.52 | 0.0042 | 1.47 | 0.0045 | 5.47 | 1.48 | -- | -120.15 | -53.18 | -158.59 | -61.85 | -12,573.30 | -- | -26,637.31 | -17,680.11 | 1.14 | -22.78 | 0.00 | -- | 138.18 | -- | -24.36 | -- | -45.17 | -- |
| Invent Medic Sweden AB | 6.91m | -8.34m | 29.29m | 8.00 | -- | 8.49 | -- | 4.24 | -0.2176 | -0.2176 | 0.1798 | 0.0801 | 0.5673 | 2.14 | 3.79 | 863,296.30 | -68.50 | -97.56 | -109.24 | -121.06 | 77.26 | 77.16 | -120.76 | -490.98 | 0.4874 | -16.36 | 0.3007 | -- | 115.97 | 177.53 | 28.77 | -- | -22.61 | -- |
| Miris Holding AB (publ) | 16.26m | -11.31m | 29.85m | 10.00 | -- | -- | -- | 1.84 | -0.2734 | -0.2734 | 0.393 | -0.1286 | 0.8539 | -0.1129 | 7.34 | 1,625,800.00 | -59.40 | -59.61 | -186.31 | -111.08 | 102.12 | 86.68 | -69.57 | -103.61 | 0.2251 | -11.97 | -- | -- | -17.19 | 2.53 | -20.86 | -- | -- | -- |
| Medimi AB | 3.90m | -13.85m | 30.84m | 6.00 | -- | 2.77 | -- | 7.91 | -0.0182 | -0.0182 | 0.0048 | 0.0103 | 0.2463 | 0.6773 | 3.76 | 650,148.30 | -87.48 | -81.87 | -105.06 | -93.93 | 51.85 | 4.06 | -355.15 | -840.93 | 4.00 | -65.57 | 0.2183 | -- | 75.13 | 280.69 | 7.52 | -- | -- | -- |
| Chordate Medical Holding AB (publ) | 1.11m | -28.09m | 35.44m | 3.00 | -- | 1.28 | -- | 31.82 | -0.0906 | -0.0906 | 0.0036 | 0.0568 | 0.0289 | -0.3708 | 9.70 | 371,183.30 | -72.99 | -91.98 | -86.88 | -122.85 | 160.96 | 209.52 | -2,522.81 | -3,295.75 | 3.43 | -- | 0.00 | -- | 799.63 | 0.6511 | -4.45 | -- | -- | -- |
| Scandinavian ChemoTech AB | 4.11m | -19.26m | 41.43m | 6.00 | -- | 4.50 | -- | 10.07 | -1.28 | -1.28 | 0.2641 | 0.424 | 0.2327 | 0.3224 | 1.36 | 685,500.00 | -108.95 | -87.29 | -108.95 | -118.55 | 39.00 | 252.05 | -468.27 | -2,122.77 | -- | -15.73 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
Data as of Jul 26 2024. Currency figures normalised to Magnasense AB's reporting currency: Swedish Krona SEK
